Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03799003
Title A Study of ASP1951 in Subjects With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Arizona Clinical Research Cent Tucson Arizona 85715 United States Details
University of California Sacramento California 95817 United States Details
University of Florida, Davis C Gainesville Florida 326102 United States Details
Emory University Atlanta Georgia 30322 United States Details
Augusta University Augusta Georgia 30912 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
University of Iowa Hospitals Iowa City Iowa 52242 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
Comprehensive Cancer Nevada Las Vegas Nevada 89169 United States Details
Rutgers Cancer Institute New Brunswick New Jersey 08903 United States Details
Icahn school of Medicine at Mount Sinai New York New York 10029 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Duke University Medical Center Durham North Carolina 27705 United States Details
Hollings Cancer Center Charleston South Carolina 29425 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Multicare Regional Cancer Center Tacoma Tacoma Washington 98405 United States Details
Site CA15002 Montreal Canada Details
Site CA15005 Montreal Canada Details
Site CA15004 Ontario Canada Details
Site KR82002 Chungcheongbukdo Korea, Republic of Details
Site KR82005 Daegu Korea, Republic of Details
Site KR82001 Gyeonggi-do Korea, Republic of Details
Site KR82003 Seoul Korea, Republic of Details
Site KR82004 Seoul Korea, Republic of Details
Site KR82006 Seoul Korea, Republic of Details
Site KR82007 Seoul Korea, Republic of Details
Site TW88603 Taichung Taiwan Details
Site TW88604 Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field